Mylan (MYL)
Mylan Market Cap: 9.196B
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
MYL Market Cap Rankings
| Overall | 89th percentile | 498 of 4663 |
| Sector | 92nd percentile | 42 of 525 in Healthcare |
| Industry | 85th percentile | 2 of 14 in Drugs - Generic |
MYL Market Cap Range, Past 5 Years
| Minimum | 3.013B | Dec 2008 |
| Maximum | 10.84B | Jun 2011 |
| Average | 6.125B |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
You may also be interested in these MYL related companies
MYL News
Mylan Announces Settlement Agreement in Litigation Relating to its Generic Xopenex
May 29, 8:01AM Benzinga
May 29, 8:01AM Benzinga
Mylan Announces Settlement Agreement in Litigation Relating to its Generic Xopenex®
May 29, 8:00AM PR Newswire
May 29, 8:00AM PR Newswire
Mylan Inc. (MYL) Settles Patent Litigation with Sunovion Pharmaceuticals
May 24, 5:36PM Street Insider
May 24, 5:36PM Street Insider
Mylan Launches Generic Version of Bonviva Film Coated Tablets in the UK and Italy
May 24, 1:27PM Benzinga
May 24, 1:27PM Benzinga
Canaccord Genuity on Pharmaceuticals: Generic Valuation at Historical Trough Level Ahead of Meetings
May 21, 10:05AM Street Insider
May 21, 10:05AM Street Insider
Mylan (MYL) Unit Launches Generic Version of Sanofi-Aventis' (SNY) Plavix
May 17, 1:42PM Street Insider
May 17, 1:42PM Street Insider
Mylan Specialty L.P. Commemorates 15th Annual Food Allergy Awareness Week
May 14, 7:30AM PR Newswire
May 14, 7:30AM PR Newswire
Mylan Increases 2012 Guidance Range to $2.45 to $2.55 in Adjusted Diluted EPS
May 10, 7:30AM PR Newswire
May 10, 7:30AM PR Newswire
$TARO A Tale of 2 Public companies -> http://stks.co/3jVy $TEVA $PRGO $MYL $PFE $AMRN
about 22 days ago by imhobutdydd
about 22 days ago by imhobutdydd
News related to $MYL, currently +0.0% since open: 'Valeant posts 1Q loss on dermatology deal costs' http://stks.co/3eUi
about 28 days ago by TradeBot
about 28 days ago by TradeBot
Listen to $MYL Q1 2012 earnings call - live at 10:00 AM, ondemand after - http://stks.co/3WkN
about 35 days ago by earningscast
about 35 days ago by earningscast
7 Companies That Keep on Growing http://stks.co/3KFs $ABT $CSCO $FDX $GLD $HAS $KSS $MYL
about 48 days ago by myplaniq
about 48 days ago by myplaniq
RT @herbgreenberg My first reaction to UBS comment that $AZN could make run at $MYL: Funny how that's floated just as analysts cut Q1 est...
about 49 days ago by WallStreetBean
about 49 days ago by WallStreetBean
Busted pattern, more than avg. volume, still above 200-DMA. Off my watch list for now. (No pos.) $MYL http://chart.ly/cx8n537
about 55 days ago by jackdamn
about 55 days ago by jackdamn
$MYL filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3FFQ
about 55 days ago by MarketBrief
about 55 days ago by MarketBrief
$MYL Insider Sale: $4.6M of stock sold by Heather Bresch (Director Chief Executive Officer) on March 28, 2012 http://stks.co/38vZ
about 62 days ago by MarketBrief
about 62 days ago by MarketBrief
$TARO $APPL $PRGO $TEVA $MYL $PFE $MRK $BMY investors look at TARO -> http://stks.co/351v
about 66 days ago by imhobutdydd
about 66 days ago by imhobutdydd
$TARO $PRGO $TEVA $MYL $PFE $MRK $BMY Look at TARO's 3 year performance -> http://stks.co/33am
about 68 days ago by imhobutdydd
about 68 days ago by imhobutdydd
$myl - http://stks.co/329g says DOWN. Create a free trend analysis account now on http://stks.co/329h
about 69 days ago by tickerly
about 69 days ago by tickerly
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| MYL | 21.53 | -0.36 | -1.64% | 9.345B |
| MYJ | 16.13 | -0.14 | -0.86% | |
| MYGN | 24.98 | -0.22 | -0.87% | 2.124B |
| MYF | 15.96 | -0.14 | -0.87% | |
| MYC | 16.30 | +0.01 | +0.06% | |
| MY | 1.38 | -0.14 | -9.21% | 190.00M |
| MXWL | 6.46 | -0.60 | -8.50% | 199.16M |
| MXT | 1.15 | -0.03 | -2.54% | 40.67M |
| MVIS | 1.91 | -0.68 | -26.25% | 44.08M |
| MVG | 8.07 | +0.10 | +1.25% | 443.69M |